These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12941831)

  • 1. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.
    Liu T; Bauskin AR; Zaunders J; Brown DA; Pankhurst S; Russell PJ; Breit SN
    Cancer Res; 2003 Aug; 63(16):5034-40. PubMed ID: 12941831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.
    Kakehi Y; Segawa T; Wu XX; Kulkarni P; Dhir R; Getzenberg RH
    Prostate; 2004 Jun; 59(4):351-6. PubMed ID: 15065082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.
    Patrikainen L; Porvari K; Kurkela R; Hirvikoski P; Soini Y; Vihko P
    Eur J Clin Invest; 2007 Feb; 37(2):126-33. PubMed ID: 17217378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
    Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.
    Bauskin AR; Brown DA; Junankar S; Rasiah KK; Eggleton S; Hunter M; Liu T; Smith D; Kuffner T; Pankhurst GJ; Johnen H; Russell PJ; Barret W; Stricker PD; Grygiel JJ; Kench JG; Henshall SM; Sutherland RL; Breit SN
    Cancer Res; 2005 Mar; 65(6):2330-6. PubMed ID: 15781647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
    Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
    Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
    Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
    Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
    BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro.
    Hammamieh R; Chakraborty N; Das R; Jett M
    J Exp Ther Oncol; 2004 Oct; 4(3):195-202. PubMed ID: 15724839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells.
    Kumagai T; Tomari K; Shimizu T; Takeda K
    Int J Mol Med; 2006 Feb; 17(2):285-91. PubMed ID: 16391828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.
    Morrissey C; O'Neill A; Spengler B; Christoffel V; Fitzpatrick JM; Watson RW
    Prostate; 2005 May; 63(2):131-42. PubMed ID: 15486995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
    Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
    Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
    Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
    Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
    Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
    Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
    Lu X; Hsieh TC; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
    Bektic J; Pfeil K; Berger AP; Ramoner R; Pelzer A; Schäfer G; Kofler K; Bartsch G; Klocker H
    Prostate; 2005 Sep; 64(4):332-40. PubMed ID: 15754346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.